Ralf Seip, Ph.D.

Chief Technology Officer

Dr. Ralf Seip is responsible for defining and executing the long-range direction of the Company’s technology function, specifically focused on bringing to market new therapeutic ultrasound offerings to the Company's clients and customers.

He has been making contributions to the field of therapeutic ultrasound for more than 25 years, spanning the entire product development cycle, from fundamental research and development activities in HIFU, array and electronics design, ultrasound mediated drug and gene delivery applications, etc., to system design, through pre-clinical and clinical validation activities, and subsequent product introduction and support. Dr. Seip was a key contributor to the development of the Company’s Sonablate and Sonatherm products during his tenure at Focus Surgery, Inc., and has recently re-joined Sonacare after continuing to develop therapeutic ultrasound solutions at Philips Research North America. Ralf is a member of the IEEE Ultrasonics Technical Program Committee, a Senior Member of the IEEE, technical journal reviewer, holds numerous patents and publications in the field of therapeutic ultrasound, and obtained his PhD in Electrical Engineering:Systems, from the University of Michigan in Ann Arbor in 1996.

Return To Team Page

HIFU company


10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384


Mon - Fri: 9:00 - 5:00

Latest News

26 September 2017

Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017 CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare...

29 August 2017

CHARLOTTE, N.C., August 30, 2017 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces today the successful collaboration with BK Ultrasound, achieving compatibility...